Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Journal of Clinical Psychopharmacology
|
November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study
Rebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 30, 2019
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial
Rebecca Schennach, Michael Riedel, Michael Obermeier, et al.
The International Journal of Neuropsychopharmacology
|
June 25, 2017
How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial
Mazda Adli, Katja Wiethoff, Thomas C Baghai, et al.
International Journal of Methods in Psychiatric Research
|
July 17, 2015
Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods
Rebecca Schennach, Hans-Jürgen Möller, Michael Obermeier, et al.
Psychiatry Research
|
March 17, 2012
One-year functional outcomes of naturalistically treated patients with schizophrenia
Ilja Spellmann, Michael Riedel, Rebecca Schennach, et al.
Schizophrenia Research
|
May 30, 2019
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression
Rebecca Schennach, Michael Obermeier, Ilja Spellmann, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
October 28, 2016
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies
Ilja Spellmann, Rebecca Schennach, Florian Seemüller, et al.
Der Nervenarzt
|
July 17, 2019
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]
Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>
Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt
|
November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]
Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Journal of Clinical Psychopharmacology
|
November 25, 2010
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study
Rebecca Schennach-Wolff, Michael Obermeier, Florian Seemüller, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
August 30, 2019
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial
Rebecca Schennach, Michael Riedel, Michael Obermeier, et al.
The International Journal of Neuropsychopharmacology
|
June 25, 2017
How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial
Mazda Adli, Katja Wiethoff, Thomas C Baghai, et al.
International Journal of Methods in Psychiatric Research
|
July 17, 2015
Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods
Rebecca Schennach, Hans-Jürgen Möller, Michael Obermeier, et al.
Psychiatry Research
|
March 17, 2012
One-year functional outcomes of naturalistically treated patients with schizophrenia
Ilja Spellmann, Michael Riedel, Rebecca Schennach, et al.
Schizophrenia Research
|
May 30, 2019
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression
Rebecca Schennach, Michael Obermeier, Ilja Spellmann, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
October 28, 2016
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies
Ilja Spellmann, Rebecca Schennach, Florian Seemüller, et al.
Der Nervenarzt
|
July 17, 2019
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]
Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>
Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt
|
November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]
Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Page
of 10